EDOC


Telemedicine & Digital Health ETF

Reasons to Consider EDOC

High Growth Potential

The global telemedicine market increased over 8% from 2022 to 2023, exceeding $94bn. Forecasts suggest the market could reach over $286bn by 2028.1

Leveraging Artificial Intelligence

AI could be the missing link to achieve transformative digitization in the Health Care sector. In the U.S. alone, it's estimated that AI could save as much as 10% of annual health care spending.2

Expanding Use Cases

Following success in diabetic monitoring, wearables are expanding into cardiovascular care. The potential market could be enormous, as an estimated 33mm people have atrial fibrillation3 and some 1.28bn adults have hypertension.4

1Fortune Business Insights, Jul 2023
2National Bureau of Economic Research, Jan 2023
3Frontiers in Public Health, Jun 2023
4World Health Organization, Mar 2023

Key Information As of 06/12/24

Inception Date 07/29/20
Total Expense Ratio 0.68%
Net Assets $46.94 million
NAV $9.33
Fact Sheet View the document

ETF Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

ETF Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Trading Details As of 06/12/24

Ticker EDOC
Bloomberg Index Ticker SOLEDOC
CUSIP 37954Y285
ISIN US37954Y2853
Primary Exchange Nasdaq
Shares Outstanding 5,030,000
Number of Holdings 40
30-Day Median Bid-Ask Spread 0.95%

Distributions As of 06/12/24

30-Day SEC Yield 0.18%
Distribution Frequency Semi-Annually

ETF Prices As of 06/12/24

NAV $9.33 Daily Change $0.03 0.32%
Market Price $9.26 Daily Change $0.04 0.43%

Performance History

As of recent
(03/31/24)
As of recent
(03/31/24)
Fund NAV Market Price Index
1 Year -19.00% -18.86% -18.54%
3 Years -20.63% -20.77% -20.28%
Since Inception -11.92% -12.02% -11.52%
1 Year -18.58% -18.38% -18.03%
3 Years -21.03% -21.02% -20.70%
Since Inception -12.62% -12.64% -12.19%
Year-to-Date -6.00% -6.03% -5.87%
1 Month -- -- 0.05%
3 Months -6.00% -6.03% -5.87%
Since Inception -37.27% -37.54% -36.23%
Year-to-Date -10.73% -10.47% -10.43%
1 Month 2.49% 2.95% 2.59%
3 Months -5.03% -4.73% -4.79%
Since Inception -40.43% -40.49% -39.31%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 06/12/24

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.86 HIMS HIMS & HERS HEALTH INC BN46048 23.68 96,312 2,280,668.16
4.75 DOCS DOXIMITY INC-CLASS A BMD22Y4 29.65 75,273 2,231,844.45
4.60 PODD INSULET CORP B1XGNW4 200.67 10,765 2,160,212.55
4.47 TNDM TANDEM DIABETES CARE INC BF3W461 47.35 44,303 2,097,747.05
4.40 RMD RESMED INC 2732903 210.89 9,799 2,066,511.11
4.27 TWST TWIST BIOSCIENCE CORP BGKG6G7 52.44 38,200 2,003,208.00
4.15 OSCR OSCAR HEALTH -A BKY83Q6 19.06 102,299 1,949,818.94
4.08 QGEN QIAGEN N.V. BMGBZP0 44.23 43,329 1,916,441.67
3.87 DGX QUEST DIAGNOSTICS INC 2702791 138.83 13,078 1,815,618.74
3.77 6618 HK JD HEALTH BMW8R04 3.13 565,200 1,769,552.08
3.74 MASI MASIMO CORP B1YWR63 132.59 13,242 1,755,756.78
3.71 A AGILENT TECHNOLOGIES INC 2520153 133.16 13,084 1,742,265.44
3.62 LH LABCORP HOLDINGS INC BSBK800 196.36 8,656 1,699,692.16
3.46 IQV IQVIA HOLDINGS INC BDR73G1 217.46 7,466 1,623,556.36
3.39 ILMN ILLUMINA INC 2613990 108.51 14,643 1,588,911.93
3.37 241 HK ALIBABA HEALTH BRXVS60 0.45 3,480,700 1,582,257.92
3.26 DXCM DEXCOM INC B0796X4 117.20 13,046 1,528,991.20
3.05 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 92.50 15,467 1,430,697.50
3.04 EVH EVOLENT HEALTH INC - A BYLY8H1 23.19 61,508 1,426,370.52
2.97 AMN AMN HEALTHCARE 2813552 53.55 26,015 1,393,103.25
2.75 RCM R1 RCM INC BP2S437 12.41 104,144 1,292,427.04
2.63 PRVA PRIVIA HEALTH GROUP INC BMDP209 17.50 70,403 1,232,052.50
2.51 TDOC TELADOC HEALTH INC BYQRFY1 10.20 115,673 1,179,864.60
2.38 VCYT VERACYTE INC BFTWZY0 22.07 50,642 1,117,668.94
1.90 OMCL OMNICELL INC 2789523 29.03 30,787 893,746.61
1.58 PHR PHREESIA INC BKF9DQ8 20.42 36,348 742,226.16
1.10 1833 HK PING AN HEALTHCA BDRYVB3 1.44 359,200 517,913.28
1.08 COP GR COMPUGROUP MEDIC BMY7CH1 27.75 18,250 506,400.03
1.01 DH DEFINITIVE HEALT BMGSDK2 6.00 79,212 475,272.00
0.99 GDRX GOODRX HOLDIN-A BMTVQT8 8.85 52,490 464,536.50
0.75 PACB PACIFIC BIOSCIEN B4N8MH9 1.98 177,407 351,265.86
0.69 LFST LIFESTANCE HEALT BN0TRB7 5.47 59,044 322,970.68
0.66 4480 JP MEDLEY INC BK93ZN7 22.40 13,829 309,786.64
0.65 4483 JP JMDC INC BK7C5Q9 21.52 14,084 303,023.64
0.58 FLGT FULGENT GENETICS INC BYQBFQ5 19.87 13,698 272,179.26
0.42 TALK TALKSPACE INC BP7L970 2.38 83,087 197,747.06
0.40 228760 KS GENOMICTREE INC BYNNYF6 15.84 11,755 186,221.20
0.39 DCGO DOCGO INC BKP4P23 3.15 57,674 181,673.10
0.36 LFMD LIFEMD INC BMXDBQ2 7.95 21,250 168,831.25
0.27 SENS SENSEONICS HOLDINGS INC BYQNYR5 0.40 317,432 126,972.80
0.06 CASH 1.00 26,051 26,050.57
0.02 OTHER PAYABLE & RECEIVABLES 1.00 9,290 9,290.03
0.00 AUSTRALIAN DOLLAR 0.67 837 560.01
0.00 EURO 1.08 1 1.04
0.00 HONG KONG DOLLAR 0.13 4 0.51
0.00 TAIWAN DOLLAR 0.03 1 0.03
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 05/31/24

Sector Weight (%)
Health Care 89.7
Financials 4.9
Consumer Discretionary 4.1
Information Technology 0.9
Consumer Staples 0.4

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Medical Specialties 34.2
Services to the Health Industry 13.6
Medical/Nursing Services 10.0
Miscellaneous Commercial Services 7.0
Biotechnology 6.9
Internet Software/Services 6.0
Information Technology Services 5.9
Data Processing Services 5.1
Managed Health Care 4.9
Hospital/Nursing Management 3.1
Packaged Software 2.6
Other 0.7

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 84.0
China 5.5
Netherlands 4.3
Hong Kong 3.4
Japan 1.2
Germany 1.2
South Korea 0.4

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 06/12/24

Return on Equity 3.70%
Weighted Avg. Market Cap 11,921 M
2023 2024
Price-to-earnings 95.44 68.03
Price-to-book value 2.57 2.49

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 05/31/24

Versus Beta
S&P 500 1.08
NASDAQ-100 0.81
MSCI EAFE 1.13
MSCI Emg. Mkts 0.93
Standard Deviation 24.50%

Source: new windowAltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.